Tumor-Promoting ATAD2 and Its Preclinical Challenges

Area of Science:

• Molecular oncology
• Epigenetics
• Cancer biology

Background:

• The ATAD2 gene is recognized as a potential oncogene implicated in tumor promotion across numerous cancers.
• ATAD2 is a conserved protein featuring AAA ATPase and bromodomain functionalities, crucial for its biological roles.

Purpose of the Study:

• To review the multifaceted role of ATAD2 in diverse human malignancies.
• To identify potential pharmacological strategies targeting ATAD2.
• To elucidate ATAD2's involvement in tumorigenesis, cancer progression, and therapeutic resistance.

Main Methods:

• Comprehensive literature review on ATAD2's function and expression in various cancers.
• Analysis of ATAD2's involvement in epigenetic regulation and oncogenic signaling pathways.
• Examination of ATAD2's association with clinical outcomes and treatment resistance.

Main Results:

• ATAD2 is highly expressed in gastrointestinal, reproductive, urological, and lung cancers, among others.
• ATAD2 contributes to oncogenesis, progression, and chemoresistance by activating signaling pathways.
• Targeting ATAD2's bromodomain presents significant challenges.

Conclusions:

• ATAD2 is a critical oncogene across multiple cancer types, with varying mechanisms of action.
• Understanding ATAD2's oncogenic roles is essential for developing targeted therapies.
• Further research into novel pharmacological approaches is warranted.